Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)
Clinical trial NCT06326697 · COMPLETED
Trial details
- NCT number
- NCT06326697
- Sponsor
- Hikma Pharmaceuticals LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-02
- Primary completion
- 2025-08-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.